Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer
Status:
Active, not recruiting
Trial end date:
2021-12-15
Target enrollment:
Participant gender:
Summary
This phase II trial studies the side effects of nab-paclitaxel in treating older patients
with breast cancer that has spread from where it started to nearby tissue or lymph nodes
(locally advanced) or to other places in the body (metastatic). Drugs used in chemotherapy,
such as nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by
killing the cells, by stopping them from dividing, or by stopping them from spreading.